The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

R. Joe; Y. Matsumura; A. Siddiqui; J. Foulks; M. Beg; J. Thompson; N. Yamamoto; A. Spira; J. Sarantopoulos; J. Melear; Y. Lou; C. Lebedinsky; J. Li; A. Watanabe; S. Warner

doi:10.1016/S0959-8049(22)00954-6

The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

R. Joe, Y. Matsumura, A. Siddiqui, J. Foulks, M. Beg, J. Thompson, N. Yamamoto, A. Spira, J. Sarantopoulos, J. Melear, Y. Lou, C. Lebedinsky, J. Li, A. Watanabe, S. Warner

Division of Hematology-Oncology

Resultado de la investigación: Article › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	S57-S58
Publicación	European Journal of Cancer
Volumen	174
DOI	https://doi.org/10.1016/S0959-8049(22)00954-6
Estado	Published - oct. 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Acceder al documento

10.1016/S0959-8049(22)00954-6

Otros archivos y enlaces

Citar esto

Joe, R., Matsumura, Y., Siddiqui, A., Foulks, J., Beg, M., Thompson, J., Yamamoto, N., Spira, A., Sarantopoulos, J., Melear, J., Lou, Y., Lebedinsky, C., Li, J., Watanabe, A., & Warner, S. (2022). The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. European Journal of Cancer, 174, S57-S58. https://doi.org/10.1016/S0959-8049(22)00954-6

Joe, R, Matsumura, Y, Siddiqui, A, Foulks, J, Beg, M, Thompson, J, Yamamoto, N, Spira, A, Sarantopoulos, J, Melear, J, Lou, Y, Lebedinsky, C, Li, J, Watanabe, A & Warner, S 2022, 'The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models', European Journal of Cancer, vol. 174, pp. S57-S58. https://doi.org/10.1016/S0959-8049(22)00954-6

@article{fca19c0510b94c2f8a37bffdbabce5f8,

title = "The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models",

author = "R. Joe and Y. Matsumura and A. Siddiqui and J. Foulks and M. Beg and J. Thompson and N. Yamamoto and A. Spira and J. Sarantopoulos and J. Melear and Y. Lou and C. Lebedinsky and J. Li and A. Watanabe and S. Warner",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00954-6",

language = "English (US)",

volume = "174",

pages = "S57--S58",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

AU - Joe, R.

AU - Matsumura, Y.

AU - Siddiqui, A.

AU - Foulks, J.

AU - Beg, M.

AU - Thompson, J.

AU - Yamamoto, N.

AU - Spira, A.

AU - Sarantopoulos, J.

AU - Melear, J.

AU - Lou, Y.

AU - Lebedinsky, C.

AU - Li, J.

AU - Watanabe, A.

AU - Warner, S.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140454116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140454116&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00954-6

DO - 10.1016/S0959-8049(22)00954-6

M3 - Article

AN - SCOPUS:85140454116

VL - 174

SP - S57-S58

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -